Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder

NCT06853665 is registered in ClinicalTrials.gov with Gagan Joshi as lead sponsor.

NCT NCT06853665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06853665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder
Lead sponsor
Gagan Joshi
Phase
Phase 4
Overall status
Recruiting
Start date
February 1, 2026
Completion date
February 1, 2030
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder (adhd), autism, autism spectrum disorder